SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020638
Filing Date
2018-11-14
Accepted
2018-11-13 18:16:08
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atos20180930_10q.htm 10-Q 592125
2 EXHIBIT 31.1 ex_126793.htm EX-31.1 11413
3 EXHIBIT 31.2 ex_126794.htm EX-31.2 11411
4 EXHIBIT 32.1 ex_126795.htm EX-32.1 6008
5 EXHIBIT 32.2 ex_126799.htm EX-32.2 6050
  Complete submission text file 0001437749-18-020638.txt   3721522

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atos-20180930.xml EX-101.INS 694765
7 XBRL TAXONOMY EXTENSION SCHEMA atos-20180930.xsd EX-101.SCH 50301
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atos-20180930_cal.xml EX-101.CAL 23585
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atos-20180930_def.xml EX-101.DEF 295124
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atos-20180930_lab.xml EX-101.LAB 263635
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atos-20180930_pre.xml EX-101.PRE 320560
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35610 | Film No.: 181179636
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1